(571) 447-5500

Tom Jonaitis co-presented a webinar with attorneys from Frost Brown Todd LLP discussing the current regulatory status of CBD products and possible FDA regulatory pathways via Generally Recognized as Safe (GRAS) and New Dietary Ingredients (NDI) for use as an ingredient in food or supplement products. Jonaitis explains both types of FDA submissions and discusses advantages and disadvantages of each. View directly on the Frost Brown Todd website.

Posted in Cannabis, EAS in Action, EAS in the News Cannabis.